Groundbreaking medical research delivers for all Australians
Join us to hear groundbreaking developments in genomics, telehealth and the growing role of AI in delivering better health outcomes for Australians.
Groundbreaking medial research delivers for all Australians.
Our health and wellbeing depend on the work of our outstanding medical researchers. At this luncheon, hear about groundbreaking developments in genomics, telehealth and the increasing application of AI in the medical field, presented by leaders in their fields.
Genomics – the study of an organism’s complete set of DNA, including all its genes, their interactions and influence on disease – is increasingly recognised as vital to our health, particularly in relation to inherited diseases and cancers. A/Professor Ness Tyrrell, Program Director of the ZERO Childhood National Cancer Program, is a leader in genomics with over 30 years of experience across all disciplines of genetic testing and research. She will speak from her broad experience in the implementation of genomics and application of rapidly emerging genomic technologies in healthcare for all Australians, and for childhood cancer in particular.
Telehealth - the management of chronic diseases at home - is becoming an increasingly important part of our health system. But how effective is telehealth? Professor Branko Celler FTSE will provide an update and address this question. He will review the CSIRO/NBN National Telehealth Trial, in which he and his team at UNSW played a vital role. The results are remarkable. For example, telehealth resulted in a reduction of 46% in medical expenditure, 53% in unscheduled hospital admissions and 41% in mortality. But what are the risks?
AI is of growing interest across healthcare, and both speakers will discuss the impacts, benefits and challenges of AI in their respective research fields.
We are fortunate to have Anne O’Neill FTSE PSM, Chief Commercial Officer, ANDHealth, introduce the event and moderate the session.
This is an event not to be missed.
Date
Thursday 16 April 2026
Time
12:00 PM - 2:00 PMCost
🎟️ $60 per person
Free for Online attendees
Free for Online attendees
Important information
12:00pm - 12:30pm AEST - Networking - In-person
12:30pm - 2:00pm AEST - Presentations and Q&A - In-person and Online
Moderator
Chief Commercial Officer, ANDHealth
Anne O’Neill has transformed NSW’s health and medical research sector into a billion-dollar innovation engine for Australia and an international investment hub.
She was architect of the phenomenally successful Medical Devices Fund and established a Commercialisation Training Program to fill a crucial gap in research translation. Her groundbreaking efforts set the blueprint for collaboration between government and industry to drive innovation and commercialisation.
Ms O’Neill has built critical capacity in Australia’s entrepreneurship ecosystem through development programs and policies that support early-stage researchers, founders, entrepreneurs and policymakers. After 30 years in NSW public service, she has recently joined ANDHealth, Australia’s leading provider of commercialisation support to evidence-based digital and connected health technologies. In her role in this female-founded and female-led organisation, she will continue to champion diversity as a mentor for women and historically underrepresented groups in STEM and healthcare.
She was architect of the phenomenally successful Medical Devices Fund and established a Commercialisation Training Program to fill a crucial gap in research translation. Her groundbreaking efforts set the blueprint for collaboration between government and industry to drive innovation and commercialisation.
Ms O’Neill has built critical capacity in Australia’s entrepreneurship ecosystem through development programs and policies that support early-stage researchers, founders, entrepreneurs and policymakers. After 30 years in NSW public service, she has recently joined ANDHealth, Australia’s leading provider of commercialisation support to evidence-based digital and connected health technologies. In her role in this female-founded and female-led organisation, she will continue to champion diversity as a mentor for women and historically underrepresented groups in STEM and healthcare.
Speakers
A/Professor Ness Tyrrell
Program Director, ZERO Childhood National Cancer Program
Program Director, ZERO Childhood National Cancer Program
Ness is Head of the Clinical Translation Research Division, and Program Director of the ZERO Childhood Cancer National Precision Medicine Program at Children’s Cancer Institute, with accountability for directing and sustaining the Program, ensuring efficient, effective, and medically responsible delivery of all aspects of the program, and building it into a sustainable permanent national precision medicine platform supporting research driven clinical care in the long term.
With over 30 years of experience in all disciplines of genetic testing in both public and private pathology and research sectors, global biotech commercial industry experience, and over 25 years of continuous active voluntary service to peak professional bodies, Ness is a recognised leader in her field.
With over 30 years of experience in all disciplines of genetic testing in both public and private pathology and research sectors, global biotech commercial industry experience, and over 25 years of continuous active voluntary service to peak professional bodies, Ness is a recognised leader in her field.
Professor, University of New South Wales
Professor Branko Celler is an internationally regarded leader in the field of Telehealth. Leveraging the research expertise, he developed during the pioneering days of biomedical engineering in the 80s and 90s, Professor Celler was among the first to recognise the importance of community-based management of chronic disease in ageing populations.
Taking his groundbreaking research to highly successful commercialisation via Telemedcare Pty Ltd, Professor Celler has made a large, enduring impact upon the development and real-world realisation of telehealth products and services.
Taking his groundbreaking research to highly successful commercialisation via Telemedcare Pty Ltd, Professor Celler has made a large, enduring impact upon the development and real-world realisation of telehealth products and services.
